Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
NCT02602795 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2018-08-29
Summary
Before starting treatment with XR-NTX, a medication that blocks the positive effects of opioids and helps people stay off opioids, individuals who are dependent on opioids first have to endure a difficult withdrawal process. This study aims to develop and test an intervention to help people who are opioid dependent successfully complete that transition; the investigators will also develop and test a comparison condition aimed at reducing HIV risk behavior.
Conditions
- Opiate Dependence
- Sexually Transmitted Diseases
- HIV
Interventions
- BEHAVIORAL
-
Acceptance and Commitment Therapy
The intervention is based on Acceptance and Commitment Therapy and will be tailored to help participants develop target adaptive responses to negative affect and other negative internal stimuli related to opioid detoxification.
- BEHAVIORAL
-
Information Motivation Behavioral Model
This intervention is based on the Information Motivation Behavior model for HIV/STI risk reduction and is tailored to more directly address HIV/STI risk among opioid dependent patients.
Sponsors & Collaborators
-
Rhode Island Hospital
lead OTHER
Principal Investigators
-
Susan E Ramsey, Ph.D. · Rhode Island Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2018-01-31
- Completion
- 2018-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1
NCT00142935 ·Status: COMPLETED ·Phase: NA
-
Distress Tolerance and Buprenorphine
NCT01556087 ·Status: COMPLETED ·Phase: PHASE3
-
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients
NCT01645033 ·Status: COMPLETED ·Phase: NA
-
Anxiety Sensitivity Treatment for Heroin Users
NCT01196312 ·Status: COMPLETED ·Phase: NA
-
Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence
NCT00548275 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse
NCT00292123 ·Status: COMPLETED ·Phase: PHASE1
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NCT04927143 ·Status: RECRUITING ·Phase: NA
-
Behavioral Drug and HIV Risk Reduction Counseling With MMT in China
NCT01389180 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
NCT00000240 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution
NCT01560221 ·Status: COMPLETED ·Phase: PHASE1
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NCT03135886 ·Status: RECRUITING ·Phase: NA
-
Improving Treatment and Recovery Services for Individuals With Opioid Problems
NCT05129813 ·Status: UNKNOWN
-
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
NCT01389167 ·Status: COMPLETED ·Phase: PHASE3
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
NCT06033599 ·Status: RECRUITING ·Phase: PHASE3
-
Aprepitant Effects in Intravenous Heroin Dependence
NCT01527994 ·Status: COMPLETED ·Phase: PHASE1
-
Directly Administered HIV Therapy in Methadone Clinics
NCT00279110 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
NCT01999946 ·Status: COMPLETED ·Phase: PHASE4
-
Treating the Partners of Drug Using Pregnant Women: Stage II
NCT00496990 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Distress Tolerance for Benzodiazepine Discontinuation
NCT05250570 ·Status: TERMINATED ·Phase: NA
-
Testing of the Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs Program
NCT04531670 ·Status: COMPLETED ·Phase: NA
-
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
NCT07073924 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794 ·Status: COMPLETED ·Phase: NA
-
TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051
NCT02730403 ·Status: COMPLETED
-
Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users
NCT00270257 ·Status: TERMINATED ·Phase: PHASE3
-
Prescribe to Save Lives
NCT03175640 ·Status: COMPLETED ·Phase: NA